DENDREON TARGETING CANCER, TRANSFORMING LIVES Trademark
DENDREON TARGETING CANCER, TRANSFORMING LIVES is a USPTO trademark filed by Dendreon Pharmaceuticals LLC. Status: Registered.
Trademark Facts
| Mark | DENDREON TARGETING CANCER, TRANSFORMING LIVES |
|---|---|
| Serial Number | 90243305 |
| Registration Number | 6408192 |
| Status | Registered |
| Filing Date | 2020-10-08 |
| Registration Date | 2021-07-06 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Dendreon Pharmaceuticals LLC |
| Attorney of Record | Diane L. Gardner |
| Prosecution Events | 19 |
| Latest Event | REAP on 2024-12-04 |
Goods & Services
Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases